STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.
View all
Clarametyx Biosciences, Inc.
Grant • Columbus, United States
Xylyx Bio
Grant • Bar Hill, United Kingdom
Answer Pay
Grant • Leeds, United Kingdom
Theolytics
Series A • Oxford, United Kingdom
Kalium Health
Grant • Girton, United Kingdom
Qkine
Seed • Cambridge, United Kingdom
Edinburgh Molecular Imaging
Non Equity Assistance • Scotland, United Kingdom
Cobra Biologics
Grant • Keele, United Kingdom
Bold Health
Grant • London, United Kingdom
Pathotrak
Grant • College Park, United States
AVM Biotech
Grant • Seattle, United States
Charm Therapeutics
Series A • London, United Kingdom